Professor Parikh’s research interests focus on translational studies of malaria in sub-Saharan Africa. Dr. Parikh focuses upon several aspects of malaria in sub-Saharan Africa, including studies on optimizing treatment regimens, novel chemoprevention strategies, drug resistance emergence and spread, and parasite dynamics. Current projects include: (1) understanding host factors affecting response to artemisinin-based antimalarial therapies using a combination of individual and population-based pharmacologic approaches to inform treatment guidelines (Uganda and Burkina Faso); 2) cluster-randomized trial of endectocides to reduce malaria transmission and morbidity (Burkina Faso); and 3) characterizing the epidemiology of antimalarial drug resistance and non-falciparum species in sub-Saharan Africa (Cameroon and Burkina Faso), 4) testing of a novel noninvasive diagnostic device for malaria (Cameroon). Dr. Parikh has ongoing projects in several African countries, which utilize observational and cross-sectional designs, as well as prospective clinical trials. Dr. Parikh received his M.D. degree from Johns Hopkins University School of Medicine and completed his medical residency training at the Beth Israel Deaconess Medical Center. After completing his fellowship in Infectious Diseases at the University of California, San Francisco and Masters in Public Health at UC Berkeley he joined the faculty at UCSF. He has been a member of the Department of Epidemiology of Microbial Diseases in the Yale School of Public Health and Section of Infectious Diseases in the Yale School of Medicine since 2012.
|Hecht-Albert Pilot Innovation Award for Junior Faculty||Global Health Leadership Institute||2016|